Literature DB >> 7907776

Sympathoinhibition by rilmenidine in conscious rabbits: involvement of alpha 2-adrenoceptors.

B Szabo1, R Urban, K Starke.   

Abstract

Cardiovascular and sympathetic nervous system effects of the mixed alpha 2-adrenoceptor and imidazoline receptor agonist rilmenidine were studied in conscious rabbits chronically instrumented for the recording of the firing rate of renal sympathetic fibers. Separate experiments were carried out on pithed rabbits with electrically stimulated (2 Hz) sympathetic outflow. Drugs were administered intravenously in a cumulative manner. In conscious rabbits, rilmenidine 0.1, 0.3 and 1.0 mg kg-1 dose-dependently lowered blood pressure, renal sympathetic nerve activity, heart rate and the plasma concentration of noradrenaline and adrenaline. The effect on blood pressure and plasma catecholamines was maximal after 0.3 mg kg-1 whereas heart rate and renal sympathetic nerve activity decreased further after rilmenidine 1.0 mg kg-1. Yohimbine 0.1 and 0.5 mg kg-1, when injected subsequently, attenuated and at the higher dose abolished all effects of rilmenidine. The effects of rilmenidine were also antagonized by the alpha 2-adrenoceptor antagonist 2-(2,3-dihydro-2-methoxy-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imid azole HCl (RX821002; 0.1 and 0.5 mg kg-1). Yohimbine 0.1 and 0.5 mg kg-1 did not attenuate or attenuated only slightly the decrease of heart rate and renal sympathetic nerve activity produced by infusion of vasopressin. In pithed rabbits with electrically-stimulated sympathetic outflow, yohimbine 0.1 submaximally and yohimbine 0.5 mg kg-1 maximally increased the plasma noradrenaline concentration. The experiments show by direct measurement of sympathetic nerve firing and plasma catecholamines that rilmenidine causes sympathoinhibition in conscious rabbits, presumably through central sites of action.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7907776     DOI: 10.1007/bf00167235

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  [On the mechanism of action of a new antihypertensive substance with imidazoline structure].

Authors:  W Kobinger
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

2.  Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit.

Authors:  J Feldman; E Tibiriça; G Bricca; M Dontenwill; A Belcourt; P Bousquet
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

3.  ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow.

Authors:  B Szabo; L Hedler; K Lichtwald; K Starke
Journal:  Eur J Pharmacol       Date:  1987-04-29       Impact factor: 4.432

4.  Effect of the amino-oxazoline derivative S-3341 on pre- and postjunctional alpha-adrenoceptors in isolated blood vessels.

Authors:  T J Verbeuren; F H Jordaens; L L Zonnekeyn; A G Herman
Journal:  Arch Int Pharmacodyn Ther       Date:  1986-11

5.  Desipramine inhibits sympathetic nerve activity in the rabbit.

Authors:  B Sazbo; A Schultheiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

6.  Inhibition of uptake 1 by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release.

Authors:  B Szabo; T Auberle; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

7.  Presynaptic alpha 2-autoreceptors in brain cortex: alpha 2D in the rat and alpha 2A in the rabbit.

Authors:  A U Trendelenburg; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

8.  Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland.

Authors:  V Simonneaux; M Ebadi; D B Bylund
Journal:  Mol Pharmacol       Date:  1991-08       Impact factor: 4.436

9.  Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.

Authors:  R E Gomez; P Ernsberger; G Feinland; D J Reis
Journal:  Eur J Pharmacol       Date:  1991-03-26       Impact factor: 4.432

10.  The pharmacokinetic properties of yohimbine in the conscious rat.

Authors:  J W Hubbard; S L Pfister; A M Biediger; T C Herzig; T K Keeton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

View more
  6 in total

1.  Rilmenidine and reflex renal sympathetic nerve activation in Wistar and hypertensive rats.

Authors:  T Zhang; E J Johns
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.

Authors:  N Niederhoffer; B Szabo
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Subclassification of presynaptic alpha 2-adrenoceptors: alpha 2D-autoreceptors and alpha 2D-adrenoceptors modulating release of acetylcholine in guinea-pig ileum.

Authors:  L Funk; A U Trendelenburg; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

4.  Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.

Authors:  R G Evans; W P Anderson
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Cardiovascular effects of agmatine, a "clonidine-displacing substance", in conscious rabbits.

Authors:  B Szabo; R Urban; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

6.  Contribution of alpha2-adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat.

Authors:  Andrew M Coney; Janice M Marshall
Journal:  J Physiol       Date:  2007-05-17       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.